nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.075	0.104	CbGbCtD
Topotecan—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0678	0.0942	CbGbCtD
Topotecan—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0678	0.0942	CbGbCtD
Topotecan—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.065	0.0903	CbGbCtD
Topotecan—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0503	0.0699	CbGbCtD
Topotecan—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0357	0.0496	CbGbCtD
Topotecan—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0322	0.0448	CbGbCtD
Topotecan—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0278	0.0387	CbGbCtD
Topotecan—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.027	0.0376	CbGbCtD
Topotecan—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0244	0.034	CbGbCtD
Topotecan—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0244	0.034	CbGbCtD
Topotecan—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0234	0.0326	CbGbCtD
Topotecan—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0227	0.0316	CbGbCtD
Topotecan—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0214	0.0297	CbGbCtD
Topotecan—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0214	0.0297	CbGbCtD
Topotecan—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0193	0.0269	CbGbCtD
Topotecan—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0193	0.0269	CbGbCtD
Topotecan—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0181	0.0252	CbGbCtD
Topotecan—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0167	0.0232	CbGbCtD
Topotecan—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0162	0.0225	CbGbCtD
Topotecan—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0146	0.0204	CbGbCtD
Topotecan—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0146	0.0204	CbGbCtD
Topotecan—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.014	0.0195	CbGbCtD
Topotecan—TOP1MT—lung—acquired immunodeficiency syndrome	0.00309	0.0808	CbGeAlD
Topotecan—TOP1MT—nervous system—acquired immunodeficiency syndrome	0.00287	0.0748	CbGeAlD
Topotecan—TOP1—retina—acquired immunodeficiency syndrome	0.00278	0.0727	CbGeAlD
Topotecan—TOP1MT—central nervous system—acquired immunodeficiency syndrome	0.00276	0.0721	CbGeAlD
Topotecan—TOP1MT—brain—acquired immunodeficiency syndrome	0.00219	0.0572	CbGeAlD
Topotecan—Irinotecan—ALB—acquired immunodeficiency syndrome	0.00214	1	CrCbGaD
Topotecan—TOP1MT—lymph node—acquired immunodeficiency syndrome	0.00212	0.0553	CbGeAlD
Topotecan—TOP1—blood—acquired immunodeficiency syndrome	0.00186	0.0486	CbGeAlD
Topotecan—TOP1—bone marrow—acquired immunodeficiency syndrome	0.0018	0.0471	CbGeAlD
Topotecan—TOP1—spinal cord—acquired immunodeficiency syndrome	0.00179	0.0469	CbGeAlD
Topotecan—TOP1—vagina—acquired immunodeficiency syndrome	0.00173	0.0451	CbGeAlD
Topotecan—TOP1—lung—acquired immunodeficiency syndrome	0.00163	0.0426	CbGeAlD
Topotecan—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00126	0.0328	CbGeAlD
Topotecan—TOP1—brain—acquired immunodeficiency syndrome	0.00116	0.0302	CbGeAlD
Topotecan—TOP1—lymph node—acquired immunodeficiency syndrome	0.00112	0.0292	CbGeAlD
Topotecan—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000889	0.0232	CbGeAlD
Topotecan—ABCG2—blood—acquired immunodeficiency syndrome	0.000661	0.0173	CbGeAlD
Topotecan—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000639	0.0167	CbGeAlD
Topotecan—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000636	0.0166	CbGeAlD
Topotecan—ABCG2—vagina—acquired immunodeficiency syndrome	0.000612	0.016	CbGeAlD
Topotecan—ABCG2—lung—acquired immunodeficiency syndrome	0.000579	0.0151	CbGeAlD
Topotecan—ABCB1—retina—acquired immunodeficiency syndrome	0.000487	0.0127	CbGeAlD
Topotecan—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000483	0.0126	CbGeAlD
Topotecan—CYP3A4—blood—acquired immunodeficiency syndrome	0.00046	0.012	CbGeAlD
Topotecan—ABCG2—brain—acquired immunodeficiency syndrome	0.00041	0.0107	CbGeAlD
Topotecan—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000396	0.0103	CbGeAlD
Topotecan—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000374	0.00976	CbGeAlD
Topotecan—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00036	0.00939	CbGeAlD
Topotecan—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000346	0.00904	CbGeAlD
Topotecan—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000342	0.00893	CbGeAlD
Topotecan—ABCB1—blood—acquired immunodeficiency syndrome	0.000326	0.00851	CbGeAlD
Topotecan—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000315	0.00823	CbGeAlD
Topotecan—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000314	0.0082	CbGeAlD
Topotecan—ABCB1—vagina—acquired immunodeficiency syndrome	0.000302	0.00789	CbGeAlD
Topotecan—ABCB1—lung—acquired immunodeficiency syndrome	0.000286	0.00746	CbGeAlD
Topotecan—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000264	0.00691	CbGeAlD
Topotecan—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000255	0.00665	CbGeAlD
Topotecan—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.000956	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00023	0.000956	CcSEcCtD
Topotecan—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.000955	CcSEcCtD
Topotecan—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000229	0.000952	CcSEcCtD
Topotecan—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000228	0.000951	CcSEcCtD
Topotecan—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000228	0.000949	CcSEcCtD
Topotecan—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.000945	CcSEcCtD
Topotecan—Rash—Didanosine—acquired immunodeficiency syndrome	0.000227	0.000943	CcSEcCtD
Topotecan—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.000943	CcSEcCtD
Topotecan—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000226	0.000943	CcSEcCtD
Topotecan—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000226	0.000943	CcSEcCtD
Topotecan—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000226	0.000942	CcSEcCtD
Topotecan—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.000938	CcSEcCtD
Topotecan—Headache—Didanosine—acquired immunodeficiency syndrome	0.000225	0.000937	CcSEcCtD
Topotecan—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000225	0.000936	CcSEcCtD
Topotecan—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000224	0.000935	CcSEcCtD
Topotecan—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.000933	CcSEcCtD
Topotecan—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000224	0.000932	CcSEcCtD
Topotecan—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000223	0.00093	CcSEcCtD
Topotecan—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000223	0.000929	CcSEcCtD
Topotecan—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.000926	CcSEcCtD
Topotecan—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000222	0.000924	CcSEcCtD
Topotecan—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000222	0.000923	CcSEcCtD
Topotecan—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000221	0.000922	CcSEcCtD
Topotecan—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000221	0.000922	CcSEcCtD
Topotecan—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000221	0.00092	CcSEcCtD
Topotecan—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000221	0.000919	CcSEcCtD
Topotecan—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00022	0.000918	CcSEcCtD
Topotecan—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.000917	CcSEcCtD
Topotecan—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.000916	CcSEcCtD
Topotecan—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00022	0.000915	CcSEcCtD
Topotecan—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00022	0.000915	CcSEcCtD
Topotecan—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00022	0.000915	CcSEcCtD
Topotecan—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000219	0.000912	CcSEcCtD
Topotecan—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000219	0.000912	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.000909	CcSEcCtD
Topotecan—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000218	0.000906	CcSEcCtD
Topotecan—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000217	0.000905	CcSEcCtD
Topotecan—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000217	0.000905	CcSEcCtD
Topotecan—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.000905	CcSEcCtD
Topotecan—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.000904	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000217	0.000904	CcSEcCtD
Topotecan—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.000903	CcSEcCtD
Topotecan—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.000902	CcSEcCtD
Topotecan—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000216	0.000898	CcSEcCtD
Topotecan—Pain—Indinavir—acquired immunodeficiency syndrome	0.000216	0.000898	CcSEcCtD
Topotecan—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000215	0.000897	CcSEcCtD
Topotecan—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000214	0.000892	CcSEcCtD
Topotecan—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000214	0.000892	CcSEcCtD
Topotecan—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000214	0.000891	CcSEcCtD
Topotecan—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000214	0.000891	CcSEcCtD
Topotecan—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.00089	CcSEcCtD
Topotecan—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000213	0.000888	CcSEcCtD
Topotecan—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000213	0.000888	CcSEcCtD
Topotecan—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.000884	CcSEcCtD
Topotecan—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.000884	CcSEcCtD
Topotecan—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.000881	CcSEcCtD
Topotecan—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.000881	CcSEcCtD
Topotecan—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.000881	CcSEcCtD
Topotecan—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00021	0.000875	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.000875	CcSEcCtD
Topotecan—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00021	0.000873	CcSEcCtD
Topotecan—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.00087	CcSEcCtD
Topotecan—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000208	0.000865	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.000865	CcSEcCtD
Topotecan—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.000862	CcSEcCtD
Topotecan—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.000861	CcSEcCtD
Topotecan—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000207	0.000861	CcSEcCtD
Topotecan—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.000861	CcSEcCtD
Topotecan—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.000859	CcSEcCtD
Topotecan—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000206	0.000859	CcSEcCtD
Topotecan—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000206	0.000858	CcSEcCtD
Topotecan—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.000856	CcSEcCtD
Topotecan—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000205	0.000855	CcSEcCtD
Topotecan—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.000855	CcSEcCtD
Topotecan—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.000852	CcSEcCtD
Topotecan—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000205	0.000852	CcSEcCtD
Topotecan—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.000848	CcSEcCtD
Topotecan—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.000848	CcSEcCtD
Topotecan—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.000848	CcSEcCtD
Topotecan—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000204	0.000848	CcSEcCtD
Topotecan—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000204	0.000847	CcSEcCtD
Topotecan—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.000846	CcSEcCtD
Topotecan—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000203	0.000846	CcSEcCtD
Topotecan—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000202	0.000843	CcSEcCtD
Topotecan—ABCB1—brain—acquired immunodeficiency syndrome	0.000202	0.00528	CbGeAlD
Topotecan—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.00084	CcSEcCtD
Topotecan—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.00084	CcSEcCtD
Topotecan—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.00084	CcSEcCtD
Topotecan—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000839	CcSEcCtD
Topotecan—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000836	CcSEcCtD
Topotecan—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.000835	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.000835	CcSEcCtD
Topotecan—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.0002	0.000834	CcSEcCtD
Topotecan—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.00083	CcSEcCtD
Topotecan—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000199	0.00083	CcSEcCtD
Topotecan—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000199	0.00083	CcSEcCtD
Topotecan—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000828	CcSEcCtD
Topotecan—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000199	0.000828	CcSEcCtD
Topotecan—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000827	CcSEcCtD
Topotecan—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000198	0.000826	CcSEcCtD
Topotecan—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.000825	CcSEcCtD
Topotecan—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000197	0.000821	CcSEcCtD
Topotecan—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000197	0.000821	CcSEcCtD
Topotecan—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.00082	CcSEcCtD
Topotecan—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.000819	CcSEcCtD
Topotecan—Rash—Stavudine—acquired immunodeficiency syndrome	0.000197	0.000819	CcSEcCtD
Topotecan—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.000818	CcSEcCtD
Topotecan—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000196	0.000818	CcSEcCtD
Topotecan—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000196	0.000817	CcSEcCtD
Topotecan—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000816	CcSEcCtD
Topotecan—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000196	0.000816	CcSEcCtD
Topotecan—Headache—Stavudine—acquired immunodeficiency syndrome	0.000195	0.000814	CcSEcCtD
Topotecan—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000195	0.000813	CcSEcCtD
Topotecan—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000195	0.0051	CbGeAlD
Topotecan—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.000811	CcSEcCtD
Topotecan—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.000811	CcSEcCtD
Topotecan—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000195	0.000811	CcSEcCtD
Topotecan—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000195	0.00081	CcSEcCtD
Topotecan—Rash—Abacavir—acquired immunodeficiency syndrome	0.000194	0.000807	CcSEcCtD
Topotecan—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000194	0.000806	CcSEcCtD
Topotecan—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.000806	CcSEcCtD
Topotecan—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000805	CcSEcCtD
Topotecan—Headache—Abacavir—acquired immunodeficiency syndrome	0.000193	0.000801	CcSEcCtD
Topotecan—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.0008	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.000799	CcSEcCtD
Topotecan—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000192	0.000799	CcSEcCtD
Topotecan—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000192	0.000799	CcSEcCtD
Topotecan—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.00079	CcSEcCtD
Topotecan—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000789	CcSEcCtD
Topotecan—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.000788	CcSEcCtD
Topotecan—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000189	0.000788	CcSEcCtD
Topotecan—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.000784	CcSEcCtD
Topotecan—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.000784	CcSEcCtD
Topotecan—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.000783	CcSEcCtD
Topotecan—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000782	CcSEcCtD
Topotecan—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.000782	CcSEcCtD
Topotecan—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000779	CcSEcCtD
Topotecan—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.000776	CcSEcCtD
Topotecan—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000186	0.000774	CcSEcCtD
Topotecan—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000186	0.000773	CcSEcCtD
Topotecan—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.000772	CcSEcCtD
Topotecan—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000185	0.000772	CcSEcCtD
Topotecan—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000185	0.000771	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000769	CcSEcCtD
Topotecan—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000768	CcSEcCtD
Topotecan—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.000763	CcSEcCtD
Topotecan—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000183	0.00076	CcSEcCtD
Topotecan—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.000758	CcSEcCtD
Topotecan—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000758	CcSEcCtD
Topotecan—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000757	CcSEcCtD
Topotecan—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000181	0.000754	CcSEcCtD
Topotecan—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000181	0.000753	CcSEcCtD
Topotecan—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.000753	CcSEcCtD
Topotecan—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.00075	CcSEcCtD
Topotecan—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.00075	CcSEcCtD
Topotecan—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.00075	CcSEcCtD
Topotecan—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.00075	CcSEcCtD
Topotecan—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000179	0.000746	CcSEcCtD
Topotecan—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000743	CcSEcCtD
Topotecan—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000178	0.000743	CcSEcCtD
Topotecan—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000734	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000734	CcSEcCtD
Topotecan—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.000731	CcSEcCtD
Topotecan—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000729	CcSEcCtD
Topotecan—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000728	CcSEcCtD
Topotecan—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.000723	CcSEcCtD
Topotecan—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.000723	CcSEcCtD
Topotecan—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.000722	CcSEcCtD
Topotecan—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.000722	CcSEcCtD
Topotecan—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000718	CcSEcCtD
Topotecan—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000173	0.000718	CcSEcCtD
Topotecan—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000172	0.000718	CcSEcCtD
Topotecan—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.000718	CcSEcCtD
Topotecan—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000171	0.000712	CcSEcCtD
Topotecan—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000171	0.000712	CcSEcCtD
Topotecan—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000171	0.000711	CcSEcCtD
Topotecan—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000709	CcSEcCtD
Topotecan—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00017	0.000707	CcSEcCtD
Topotecan—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000169	0.000702	CcSEcCtD
Topotecan—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.0007	CcSEcCtD
Topotecan—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.000699	CcSEcCtD
Topotecan—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000697	CcSEcCtD
Topotecan—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.000696	CcSEcCtD
Topotecan—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000696	CcSEcCtD
Topotecan—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000695	CcSEcCtD
Topotecan—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000167	0.000694	CcSEcCtD
Topotecan—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000694	CcSEcCtD
Topotecan—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000694	CcSEcCtD
Topotecan—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000691	CcSEcCtD
Topotecan—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000689	CcSEcCtD
Topotecan—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000689	CcSEcCtD
Topotecan—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000164	0.000681	CcSEcCtD
Topotecan—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000163	0.000679	CcSEcCtD
Topotecan—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.000671	CcSEcCtD
Topotecan—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.000671	CcSEcCtD
Topotecan—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000161	0.00067	CcSEcCtD
Topotecan—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000668	CcSEcCtD
Topotecan—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000668	CcSEcCtD
Topotecan—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00016	0.000667	CcSEcCtD
Topotecan—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000664	CcSEcCtD
Topotecan—Rash—Indinavir—acquired immunodeficiency syndrome	0.000159	0.000662	CcSEcCtD
Topotecan—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000159	0.000661	CcSEcCtD
Topotecan—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000659	CcSEcCtD
Topotecan—Headache—Indinavir—acquired immunodeficiency syndrome	0.000158	0.000658	CcSEcCtD
Topotecan—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000158	0.000656	CcSEcCtD
Topotecan—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.000649	CcSEcCtD
Topotecan—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000647	CcSEcCtD
Topotecan—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.00064	CcSEcCtD
Topotecan—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000637	CcSEcCtD
Topotecan—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000637	CcSEcCtD
Topotecan—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.000631	CcSEcCtD
Topotecan—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.00063	CcSEcCtD
Topotecan—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000627	CcSEcCtD
Topotecan—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.000625	CcSEcCtD
Topotecan—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.000625	CcSEcCtD
Topotecan—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00015	0.000623	CcSEcCtD
Topotecan—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000622	CcSEcCtD
Topotecan—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000149	0.000621	CcSEcCtD
Topotecan—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.000621	CcSEcCtD
Topotecan—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000606	CcSEcCtD
Topotecan—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000603	CcSEcCtD
Topotecan—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.0006	CcSEcCtD
Topotecan—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000598	CcSEcCtD
Topotecan—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000598	CcSEcCtD
Topotecan—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000598	CcSEcCtD
Topotecan—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.000594	CcSEcCtD
Topotecan—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000594	CcSEcCtD
Topotecan—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000589	CcSEcCtD
Topotecan—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.00058	CcSEcCtD
Topotecan—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000578	CcSEcCtD
Topotecan—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000578	CcSEcCtD
Topotecan—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.00057	CcSEcCtD
Topotecan—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.000564	CcSEcCtD
Topotecan—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000559	CcSEcCtD
Topotecan—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000558	CcSEcCtD
Topotecan—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000553	CcSEcCtD
Topotecan—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000553	CcSEcCtD
Topotecan—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000551	CcSEcCtD
Topotecan—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.00055	CcSEcCtD
Topotecan—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000537	CcSEcCtD
Topotecan—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000533	CcSEcCtD
Topotecan—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000533	CcSEcCtD
Topotecan—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000532	CcSEcCtD
Topotecan—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000529	CcSEcCtD
Topotecan—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000521	CcSEcCtD
Topotecan—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000512	CcSEcCtD
Topotecan—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000508	CcSEcCtD
Topotecan—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000508	CcSEcCtD
Topotecan—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000505	CcSEcCtD
Topotecan—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000502	CcSEcCtD
Topotecan—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000479	CcSEcCtD
